PROGNOSTIC-SIGNIFICANCE OF MUC1 EPITHELIAL MUCIN EXPRESSION IN BREAST-CANCER

被引:196
作者
MCGUCKIN, MA
WALSH, MD
HOHN, BG
WARD, BG
WRIGHT, RG
机构
[1] UNIV QUEENSLAND,ROYAL BRISBANE HOSP,DEPT SURG,HERSTON,QLD 4029,AUSTRALIA
[2] ROYAL BRISBANE HOSP,DEPT PATHOL,HERSTON,QLD,AUSTRALIA
[3] ROYAL WOMENS HOSP,DEPT GYNECOL ONCOL,HERSTON,QLD,AUSTRALIA
基金
英国医学研究理事会;
关键词
BREAST CANCER; MUCIN; PROGNOSIS; SURVIVAL; MUC1;
D O I
10.1016/0046-8177(95)90146-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The epithelial mucin produced by the MUCl gene is present in the apical cell membrane of normal breast epithelial cells and is highly expressed in many breast cancers. Several studies have provided conflicting evidence regarding the relationship between MUCl expression and survival in breast cancer patients. In this study a detailed immunohistological analysis of MUCl expression was performed using monoclonal antibody BC2 and was related to other tumor characteristics: and patient survival. Patients whose tumors showed MUCl expression in greater than 75% of tumor cells had significantly poorer disease-free and overall survival (P < .05). The proportion of cells showing cytoplasmic MUCl expression was prognostically significant, but the proportion of cells that lined gland spaces showing apical membrane staining was of no prognostic significance. A high level of MUCl expression was significantly associated with the presence of axillary node metastases and estrogen recep tors but not with other tumor characteristics. HUM PATHOL 26:432-439. Copyright (C) 1995 by W.B. Saunders Company
引用
收藏
页码:432 / 439
页数:8
相关论文
共 38 条
[1]   SURVIVAL IN BREAST-CANCER RELATED TO TUMOR ESTROGEN-RECEPTOR STATUS AND IMMUNOHISTOCHEMICAL STAINING FOR NCRC-11 [J].
ANGUS, B ;
NAPIER, J ;
PURVIS, J ;
ELLIS, IO ;
HAWKINS, RA ;
CARPENTER, F ;
HORNE, CHW .
JOURNAL OF PATHOLOGY, 1986, 149 (04) :301-306
[2]   THE EXPRESSION OF MILK-FAT GLOBULE ANTIGENS WITHIN HUMAN MAMMARY-TUMORS - RELATIONSHIP TO STEROID-HORMONE RECEPTORS AND RESPONSE TO ENDOCRINE TREATMENT [J].
BAILDAM, AD ;
HOWELL, A ;
BARNES, DM ;
TURNBULL, L ;
SELLWOOD, RA .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (03) :459-467
[3]   THE PROGNOSTIC VALUE OF THE MONOCLONAL-ANTIBODIES HMFG1 AND HMFG2 IN BREAST-CANCER [J].
BERRY, N ;
JONES, DB ;
SMALLWOOD, J ;
TAYLOR, I ;
KIRKHAM, N ;
TAYLORPAPADIMITRIOU, J .
BRITISH JOURNAL OF CANCER, 1985, 51 (02) :179-186
[4]  
BOBEK LA, 1993, J BIOL CHEM, V268, P20563
[5]  
BYRNE J, 1992, EUR J SURG ONCOL, V18, P230
[6]   LEVELS OF EXPRESSION OF BREAST EPITHELIAL MUCIN DETECTED BY MONOCLONAL-ANTIBODY BRE-3 IN BREAST-CANCER PROGNOSIS [J].
CERIANI, RL ;
CHAN, CM ;
BARATTA, FS ;
OZZELLO, L ;
DEROSA, CM ;
HABIF, DV .
INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (03) :343-354
[7]  
Cox DR, 1984, ANAL SURVIVAL DATA, pviii
[8]  
DEVINE P L, 1990, Journal of Tumor Marker Oncology, V5, P11
[9]  
DEVINE P L, 1990, Journal of Tumor Marker Oncology, V5, P321
[10]   MUCINS - STRUCTURE, FUNCTION, AND ASSOCIATIONS WITH MALIGNANCY [J].
DEVINE, PL ;
MCKENZIE, IFC .
BIOESSAYS, 1992, 14 (09) :619-625